Trial Profile
Extension trial of alpha-1 antitrypsin in alpha-1 antitrypsin deficient patients with emphysema.
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 26 May 2014
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Alpha 1-antitrypsin deficiency
- Focus Registrational; Therapeutic Use
- Sponsors Kamada
- 26 May 2014 New trial record